2005
DOI: 10.1039/b413435d
|View full text |Cite
|
Sign up to set email alerts
|

Selective attachment and release of a chemotherapeutic agent from the interior of a protein cage architecture

Abstract: The antitumor agent doxorubicin was covalently bound and selectively released in a pH dependent manner from the interior surface of a genetically modified small heat shock protein (Hsp) cage.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

1
150
0

Year Published

2008
2008
2017
2017

Publication Types

Select...
5
3

Relationship

2
6

Authors

Journals

citations
Cited by 158 publications
(151 citation statements)
references
References 19 publications
(31 reference statements)
1
150
0
Order By: Relevance
“…[6][7][8][9][10][11][12][13] However, it is still challenging to manipulate their self-assembly in a controlled way and to analyze their assembled products precisely at the molecular level. 14,15 In this study, we have generated two different individual mutants of a protein cage with functional groups either inside or outside of the cage ( Figure 1A).…”
mentioning
confidence: 99%
“…[6][7][8][9][10][11][12][13] However, it is still challenging to manipulate their self-assembly in a controlled way and to analyze their assembled products precisely at the molecular level. 14,15 In this study, we have generated two different individual mutants of a protein cage with functional groups either inside or outside of the cage ( Figure 1A).…”
mentioning
confidence: 99%
“…In particular, macromolecular prodrugs based on polymerdrug [6][7][8][9][10] and protein-drug conjugates 11,12 have received considerable attention. Unlike liposomes and polymeric micelles from which encapsulated drugs tend to be released in the bloodstream before accumulating at their target site through dissociation of thermodynamically self-assembled structures, 13,14 drug-carrier conjugates can be kept in a stable conformation if appropriate linkers are used.…”
Section: Introductionmentioning
confidence: 99%
“…[22][23][24][25] Although Hsp cages have several favorable characteristics making them suitable as drug carriers, to the best of the authors' knowledge, only a few reports have examined this possibility. 11 In this study, an Hsp cage-based prodrug was developed. Doxorubicin (DOX) was used as a model drug because it has been clinically used to treat many cancers for more than four decades.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Protein cage structures such as those mentioned above have been studied for their potential in materials synthesis [7,12], catalysis [13,14], drug and gene delivery [15,16], bio-imaging [17][18][19], cell targeting [20,21], and vaccine development [11]. VLPs in particular are promising, as they exist in a large range of sizes (tens to hundreds of nanometers), have well-defined, monodisperse structures, can be purified in large quantities, and can be easily modified both genetically and chemically [22][23][24][25][26][27].…”
Section: Introductionmentioning
confidence: 99%